Management of Anticoagulants and Antithrombotics in Patients With CSDH

Thromboembolic and Hemorrhagic Risk Evaluation in Surgically Treated Patients With CSDH Taking Anticoagulants and Antithrombotics

Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.

Inclusion Criteria:

• Age > 18 years old
• Informed consent
• Evidence of CSDH which needs surgery
• patients taking antithrombotics or anticoagulants

Exclusion Criteria:

• previous surgery for CSDH